Trials / Recruiting
RecruitingNCT05262907
Ventripoint Single Ventricle Study
Assessment of Ventricular Volumes and Function in Single Ventricle Patients Using Ventripoint 3D Echocardiography
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.
Detailed description
The accuracy of current echocardiographic techniques for measuring ventricular size and function are limited by geometric assumptions, which are particularly problematic in malformed hearts or functional single ventricles, as well as the inability to visualize the entire heart at one time from a single imaging window, and higher heart rates degrading 3D imaging volume rates. This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles, including a comparison to the gold standard of cardiac MRI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transthoracic Echocardiogram or Cardiac MRI | Non-invasive imaging of the heart to evaluate structure and function. |
| DEVICE | Ventripoint Echocardiogram | Non-invasive ultrasound of the heart to evaluate structure and function through 3D imaging. |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2027-08-01
- Completion
- 2027-08-01
- First posted
- 2022-03-02
- Last updated
- 2025-10-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05262907. Inclusion in this directory is not an endorsement.